Allspring Global Investments
APGE icon

Allspring Global Investments’s Apogee Therapeutics APGE Stock Holding History

Allspring Global Investments’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$510K Buy
6,052
+617
+11% +$44.8K ﹤0.01% 1385
2025
Q4 		$412K Buy
+5,435
New +$342K ﹤0.01% 1428
2025
Q3 		– Sell
-4,931
Closed -$218K – 1631
2025
Q2 		$218K Buy
+4,931
New +$188K ﹤0.01% 1532
2024
Q4 		– Sell
-3,378
Closed -$198K – 1786
2024
Q3 		$198K Sell
3,378
-251
-7% -$12K ﹤0.01% 1673
2024
Q2 		$143K Buy
+3,629
New +$176K ﹤0.01% 1782

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Allspring Global Investments's APGE Position: Q1 2026 in Review

Allspring Global Investments increased its Apogee Therapeutics (APGE) stake by 11% in Q1 2026, buying an estimated $44.8K and bringing the position to 6,052 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

Allspring Global Investments first reported a position in APGE in Q2 2024 and has held it in 5 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Allspring Global Investments held 6,052 shares of Apogee Therapeutics worth $510K as of Q1 2026.
  • Allspring Global Investments bought 617 Apogee Therapeutics shares in Q1 2026, an estimated $44.8K.
  • Apogee Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1385 holding.
  • Allspring Global Investments first reported a position in Apogee Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.